Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 12,710,762	$ 5,761,568
Collaboration receivable	5,000,000
Prepaid expenses	1,094,229	510,635
Other current assets	9,283,625	168,826
Total current assets	28,088,616	6,441,029
Property and equipment, net	114,112	130,081
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	406,956	395,311
Total assets	36,256,951	14,613,688
Current liabilities:
Accounts payable	1,405,734	1,672,109
Accrued expenses	2,428,193	3,781,101
Deferred collaboration funding, current	15,825,938
Other current liabilities	9,450,085	692,336
Total current liabilities	29,109,950	6,145,546
Deferred collaboration funding, non-current	8,661,109
Other non-current liabilities	209,497	243,808
Total liabilities	37,980,556	6,389,354
Commitments and Contingencies (Note 6)
Stockholders’ (deficit) equity:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 14,310,244 and 13,233,137 shares issued and outstanding at December 31, 2021 and 2020, respectively	1,431	1,324
Additional paid-in capital	112,784,918	107,358,971
Accumulated deficit	(114,509,954)	(99,135,961)
Total stockholders’ (deficit) equity	(1,723,605)	8,224,334
Total liabilities and stockholders’ (deficit) equity	$ 36,256,951	$ 14,613,688